Evidence map›Paper›PMID 37360397›Full record

ArticleRSC medicinal chemistry2023

Novel pirfenidone derivatives: synthesis and biological evaluation.

Maoling Yao, Maoru Sun, Congdi Chen, Liming Jin, Hongjun Yang, Yong Li, Shufan Yin

Open access · greenAbstract read
In one paragraph

Article in RSC medicinal chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. New analogs of 5-substituted-2(1Acta biochimica Polonica · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Maoling YaoKey Laboratory of General Chemistry of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University Chengdu 610041 China yanghj@swun.edu.cn.ORCID https://orcid.org/0009-0006-0570-771X
Maoru SunKey Laboratory of General Chemistry of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University Chengdu 610041 China yanghj@swun.edu.cn.
Congdi ChenCollege of Chemistry and Life Science, Chengdu Normal University Chengdu 611130 China.
Liming JinKey Laboratory of Biotechnology and Bioresources Utilization, Ministry of Education, Dalian Minzu University Dalian 116600 China.
Hongjun YangKey Laboratory of General Chemistry of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University Chengdu 610041 China yanghj@swun.edu.cn.
Yong LiInnovation Center of Nursing Research, Nursing Key Laboratoryof Sichuan Province, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and, Collaborative Innovation Center of Biotherapy, Sichuan University Chengdu 610041 China liyong562@126.com.
Shufan YinCollege of Chemistry, Sichuan University Chengdu 610000 China.
State Ethnic Affairs Commission · CNSichuan University · CNChengdu Normal University · CNDalian Minzu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to discover novel anti-pulmonary fibrosis agents, a series of novel pirfenidone derivatives were designed and synthesized. All compounds were investigated for their anti-pulmonary activity and characterized by

Identifiers

PMID37360397
PMCPMC10285743
OpenAlexW4381936711

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.